Home » News & Resources » Publications

Publications

Utility of incorporation of beta-D-glucan and T2Candida testing for diagnosis and treatment of candidemia

The T2Bacteria Panel Identifies 3 Times More On-Panel Bacterial Pathogens Compared to Conventional Blood Culture

Is the T2MR Candida Panel a suitable alternative to the SeptiFast for the rapid diagnosis of candidemia in routine clinical practice?

Prospective observational pilot study of the T2Resistance panel in the T2Dx system for detection of resistance genes in bacterial bloodstream infections

The T2Candida Panel Identifies 3.55 Times More On-Panel Candida Species Compared to Conventional Blood Culture

Performance of T2Bacteria in relationship to blood cultures – a retrospective comparative study

Evaluation of T2 Magnetic Resonance (T2MR®) Technology for the Early Detection of ESKAPEc Pathogens in Septic Patients

Using T2MR technology in critically ill septic patients: are we overcoming the limits of blood culture?

The T2Bacteria Panel Covers 74% of Bacterial Pathogens Causing Bloodstream Infections

Accuracy of T2 magnetic resonance assays as point-of-care methods in the intensive care unit

Rapid Detection of Antibiotic Resistance Genes Direct from Whole Blood Samples by T2 Magnetic Resonance (T2MR®)

Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock

Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications

Integrated Symposium

The Intersection of COVID-19 and Sepsis and the Role of Anti-Microbial Stewardship in Addressing Anti-Microbial Resistance

Application of Rapid and Innovative Molecular Diagnostic Assays to Identify Sepsis-Causing Candida Pathogens

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19

Combining T2Bacteria and T2Candida Panels for Diagnosing Intra-Abdominal Infections: A Prospective Multicenter Study

Culture Independent Diagnostics for Immunocompromised Patients with Covid-19 at Risk for Sepsis

Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population

Antimicrobial and Resource Utilization with T2 Magnetic Resonance for Rapid Diagnosis of Bloodstream Infections: Systematic Review with Meta-analysis of Controlled Studies

Direct detection of ESKAPEc pathogens from whole blood using the T2Bacteria Panel allows early antimicrobial stewardship intervention in patients with sepsis

Industry & Science Symposium: World Microbe Forum

Industry Keynote: Sepsis Tech and Innovation

Prospective Study of the T2Resistance System for Detection of Resistance Genes in Bacterial Bloodstream Infections

T2Bacteria Panel: Clinical Impact and Comparison with Blood Culture and Multiplex Real-time PCR

Preliminary Evaluation of T2Candida Panel for the Diagnosis of Invasive Candidiasis in Critically Ill Patients

Performance of T2 Magnetic Resonance (T2MR) for the Diagnosis of Bloodstream Infections (BSI) in Paediatric Patients

Integrated Symposium at ECCMID 2021

Development of a rapid, high sensitivity, direct from blood assay for identification of biothreat organisms

Impact of Blood Culture Independent Rapid Diagnostics and Early Identification of Sepsis Causing Pathogens

T2SARS-CoV-2 Panel is able to detect all SARS-CoV-2 variants as confirmed by genomic surveillance

Utilization of a novel diagnostic assay to improve turnaround time and accurate diagnosis and treatment of secondary Candidemia in a critically ill immunosuppressed COVID-19 patient

Performance of the T2Resistance Panel in Detecting Antibiotic Resistance Bacteria Directly in Whole Blood…

T2 magnetic resonance technology in the diagnosis of sepsis and clinical impact in patient management

Evaluation of T2MR in a Greek university intensive care unit

Using T2Dx and rapid AST with blood culture pre-sampling for combined ID and AST before blood culture positivity

T2Bacteria panel in diagnostics of sepsis: the first experience at the University Hospital Centre Zagreb

Evaluation of T2MR for the diagnosis of bloodstream infections in paediatric patients

Examining discordance in blood culture and T2 positivity in the detection of candidaemia: modelling the odds of blood culture and T2 discordance as a function of candidaemia risk factors

Early diagnosis in sepsis: T2 bacteria magnetic resonance assay versus blood culture

Prospective, non-interventional, multi-centre clinical study of the T2Resistance system for detection resistance genes in bacterial bloodstream infections: an interim analysis

The T2Bacteria assay is a sensitive and rapid detector of bacteremia that can be initiated in the emergency department and has potential to favorably influence subsequent therapy

The T2Bacteria Panel is a rapid detector of bacteremia and has potential to guide therapy in patients with hematological malignancies and hematopoietic stem cell transplantation (HSCT): a pilot study of non-culture molecular diagnostics

Rapid Diagnostics Direct from Whole Blood: A Solution for Fast and Appropriate Antimicrobial Therapy

The T2Bacteria Panel is a rapid detector of bacteremia and has potential to guide therapy in patients with hematological malignancies and hematopoietic stem cell transplantation (HSCT): a pilot study of non-culture molecular diagnostics

Development of a Highly Sensitive Assay for the Detection of Carbapenem-resistance Genes from Whole Blood by T2 Magnetic Resonance (T2MR®)

Real-life diagnostic performance of T2Candida among ICU patients with risk factors for invasive candidiasis

Evaluation of the T2 magnetic resonance molecular technology for the direct identification of pathogens from blood samples in pediatric patients with suspected sepsis

Rapid, culture-independent detection of resistance genes direct from whole blood by (T2MR®)

Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections. A Diagnostic Accuracy Study

Rapid Species Identification Using T2Direct Diagnostics™ with Stewardship Interventions

Development of a Highly Sensitive Assay for the Detection of Carbapenem-resistance Genes from Whole Blood by T2 Magnetic Resonance (T2MR®)

Clinical Performance of T2Bacteria® Panel on Whole Blood for Early Identification of Bloodstream Infections in a Tertiary Care Teaching Hospital

Blood culture-independent rapid diagnostic technology for improvement of time to bacterial species ID and earlier targeted antibiotic therapy.

A Rapid, Direct-from-Blood Diagnostic to Address Infections from Multidrug Resistant Organisms (MDROs)

Rapid, Direct-from-Blood Diagnostics that Enable Changes in Clinical Decisions

Detection of antibiotic resistance genes in clinical samples using T2 Magnetic Resonance (T2MR®)

30- Day Mortality Among Patients with Candidemia Diagnosed by T2Candida Assay Alone: Influence of Risk Factors and Candida Species

Comparison of T2Candida Assay with Blood Culture, Candida Sepsis Score and Serum Beta-D-glucan in Diagnosis of Candidemia

Evaluation of the T2Candida Panel as an Antifungal Stewardship Tool in Transplant and Non-Transplant Patients at a Tertiary Care Center

Evaluation of the clinical Impact of the T2MR for the Diagnosis of Blood Stream Infections

Optimizing the Clinical Utilization of T2 Rapid Candida Panel at a Large Community Hospital

Keynote Presentation: World Anti-Microbial Resistance Congress 2019

The T2Bacteria Assay is a Sensitive and Rapid Detector of Bacteremia that can be Initiated in the Emergency Department and has Potential to Favorably Influence Subsequent Therapy

The efficacy of T2 Magnetic Resonance assay in monitoring candidemia after the initiation of antifungal therapy: The serial therapeutic and antifungal monitoring protocol (STAMP) trial.

Detecting infections rapidly and easily for candidemia trial, part 2 (DIRECT2): A prospective, multicenter study of the T2Candida Panel

Beyond blood culture: Whole blood diagnostics and antimicrobial stewardship

T2 Magnetic Resonance assay: Overview of available data and clinical implications

PCR-based nethods for the diagnosis of invasive candidiasis: Are they ready for use in the clinic?

Comparative clinical evaluation of the T2Bacteria Panel versus blood culture for the diagnosis of bacteremia

Use of T2MR in invasive candidiasis with and without candidemia

T2 Magnetic Resonance to monitor hemostasis. In seminars in thrombosis and hemostasis.

T2Candida® to guide antifungal and length of treatment of candidemia in a pediatric multivisceral transplant recipient

Evaluation of a new T2 Magnetic Resonance assay for rapid detection of emergent fungal pathogen Candida auris on clinical skin swab samples

T2Bacteria Panel: A rapid, culture-independent assay for identification of sepsis causative agents

Evaluation of the T2Bacteria Panel (T2BP) compared to standard blood culture at Ochsner Medical Center.

Validation of a rapid diagnostic test on whole blood for early identification of pathogens in patients in the intensive care unit

Clinical performance of T2Bacteria among patients with bloodstream infections due to five common bacterial species

Diagnosing candidemia with the T2Candida Panel: An instructive case of septic shock in which blood cultures were negative

Novel T2Candida Panel assay compared to blood cultures for detection of candidemia in transplant and non-transplant patients

Impact of T2Candida Panel on species specific antifungal de-escalation

T2Candida (T2MR) versus Beta-D-Glucan for preemptive antifungals stewardship in the intensive care unit

Incorporating T2Candida testing into rational antifungal (AF) management: A successful pilot study of diagnostic stewardship directed toward specific intensive care unit patients at-risk for sepsis due to invasive candidiasis

Implementation of the T2 Biosystems T2Bacteria Panel in a level-one trauma center, safety net hospital

T2Candida® to guide antifungal and length of treatment of candidemia in a pediatric multivisceral transplant recipient

Accuracy of T2MR in diagnosing candidemia in critically ill patients: a prospective observational study

T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood

Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study

T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study

T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study

Rapid evaluation of platelet function with T2 Magnetic Resonance

T2 Magnetic Resonance-based direct detection of three Lyme disease-related Borrelia species in whole blood samples

T2 Magnetic Resonance assay improves timely management of candidemia

New frontiers in in vitro medical diagnostics by low field T2 Magnetic Resonance relaxometry

T2MR® platelet analysis enables fast and accurate diagnosis of qualitative platelet disorders in microliter volumes of whole blood

T2Candida provides rapid and accurate species identification in pediatric cases of candidemia

Performance evaluation of the T2Candida Panel in the ICU setting – Data from an ongoing study

Evaluation of BacT/Alert FA blood culture bottles and T2Candida assay for detection of Candida in the presence of antifungals

Intra-abdominal candidiasis: The importance of early source control and antifungal treatment

Investigational study: Whole blood platelet activity measurements multiplexed with quantitative fibrinogen, clot time and fibrinolysis measurements by T2MR®

Antifungal prescribing during initial implementation of candidemia early detection and species identification testing with T2Candida Panel

Novel T2 Magnetic Resonance assay compared to standard blood cultures for detection of candidemia

T2 Magnetic Resonance improves the timely management of candidemia

Performance evaluation of the T2Candida Panel in the ICU setting – Data from an ongoing study

Implementation of T2 Magnetic Resonance into the Antimicrobial Stewardship

Nanotechnology

T2 Magnetic Resonance assay for the rapid diagnosis of candidemia in whole blood: A clinical trial

The economic impact of rapid Candida species identification by T2Candida among high-risk patients

Investigational study: T2Candida provides rapid and accurate species identification in pediatric cases of candidemia

Investigational study: T2MR® platelet analysis correlates with LTA and reveals unique details of ADP-mediated platelet activation in whole blood

T2MR and T2Candida: Novel technology for the rapid diagnosis of candidemia and invasive candidiasis

T2Candida is more sensitive and rapid than blood culture for monitoring candidemia in patients with proven infection

T2Bacteria: Rapid and sensitive detection and identification of sepsis pathogens in whole blood specimens by T2MR®

Invasive Candidiasis

Invasive Candidiasis

A new red cell shape helps the clot

Clot contraction: Compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin

A (nother) test meant to fill the gap between in vivo and ex vivo hemostasis

T2 Magnetic Resonance: A diagnostic platform for studying integrated hemostasis in whole blood—proof of concept

Invesitgational study: Intra-abdominal candidiasis: Description of an under-appreciated disease and a case report of rapid diagnosis by whole blood T2Candida assay

Nuclear magnetic resonance nanotechnology: Applications in clinical diagnostics and monitoring

T2 Magnetic Resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood

Magnetic barcode assay for genetic detection of pathogens

A magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria

Comparison of the T2Dx Instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples

Pattern recognition of cancer cells using aptamer-conjugated magnetic nanoparticles

Fluorochrome‐functionalized magnetic nanoparticles for high‐sensitivity monitoring of the polymerase chain reaction by magnetic resonance

Palm NMR and 1-chip NMR

Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers

Miniature magnetic resonance system for point of care diagnostics

Micro-NMR for rapid molecular analysis of human tumor samples

Magnetic resonance for in vitro medical diagnostics: Superparamagnetic nanoparticle-based magnetic relaxation switches

Supramolecular host–guest interaction for labeling and detection of cellular biomarkers

Magnetic relaxation-based platform for multiplexed assays

Detection of carbohydrate binding proteins using magnetic relaxation switches

Nanomaterials‐based magnetic relaxation switch biosensors

Rapid detection and profiling of cancer cells in fine-needle aspirates

Ultrasensitive detection of bacteria using core–shell nanoparticles and an NMR‐filter system

Nanoparticle−Target interactions parallel Antibody−Protein interactions

Implantable diagnostic device for cancer monitoring

Chip–NMR biosensor for detection and molecular analysis of cells

Sensitive NMR sensors detect antibodies to influenza

Preparation of iron oxide-based calcium sensors for MRI

Magnetic relaxation switch detection of human chorionic gonadotrophin

Multi-reservoir device for detecting a soluble cancer biomarker

Continuous analyte sensing with magnetic nanoswitches

Dynamic imaging with MRI contrast agents: quantitative considerations

Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin

Magnetic relaxation switch immunosensors detect enantiomeric impurities

Novel nanosensors for rapid analysis of telomerase activity

Magnetic sensors for protease assays

Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media

DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents

Magnetic relaxation switches capable of sensing molecular interactions

Magnetic nanosensors for the detection of oligonucleotide sequences

CONTACT US

T2 Biosystems
101 Hartwell Avenue
Lexington, MA 02421
Phone: 781-457-1200
Fax: 781-357-3080

T2 BIOSYSTEMS OVERVIEW

T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today.

The T2Dx Instrument, the T2Bacteria and T2Candida Panels have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products are considered investigational and for research use only.

T2 Biosystems®, T2MR®, T2Bacteria®, T2Candida®, T2Resistance® and T2Dx® are registered trademarks of T2 Biosystems, Inc. “T2Biosystems” and the T2 Biosystems, Inc. logo design are registered trademarks or trademarks of T2Biosystems, Inc. All software and documentation is subject to T2 Biosystems, Inc. copyrights. All rights reserved. T2Direct Diagnostics™, T2HemoStat™, T2Plex™, T2Cauris™, T2Lyme™ and T2SARS-CoV-2™ are trademarks of T2 Biosystems, Inc.

© 2024 T2 Biosystems, Inc.

SITEMAP

FOLLOW US ON SOCIAL

Please tell us where you are visiting from: United States | Outside the United States